Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma
Publikation: Bidrag til tidsskrift › Kommentar/debat › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Acta Oncologica |
Vol/bind | 59 |
Udgave nummer | 12 |
Sider (fra-til) | 1547-1551 |
ISSN | 0284-186X |
DOI |
|
Status | Udgivet - 2020 |
ID: 250555335